Bhuwanatala Indah Permai Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bhuwanatala Indah Permai Tbk. trades at Rp70 (market cap 316.81B, 265.26M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bhuwanatala Indah Permai Tbk. is the larger of the two by market cap, and Bhuwanatala Indah Permai Tbk. is more actively traded (265.26M versus 214.9K). Which is the better fit depends on your goals.
| BIPP | OBAT | |
|---|---|---|
Market Cap | 316.81B | 164.65B |
Volume | 265.26M | 214.9K |
Lot | 2.65M | 2.15K |
Turnover | 19.02B | 51.97M |
Average Price | 71.72 | 241.85 |
Value | 19.02B | 51.97M |
Indicative Equilibrium Price | 70 | 240 |
Indicative Equilibrium Volume | 20.2K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bhuwanatala Indah Permai Tbk (the Company) was initially established within the framework of Domestic Capital Investment Law No. 6 year 1968 as amended by law No. 12 year 1970 based on Notarial Deed No. 165 dated December 21, 1981 of Public Notary Koswara, S.H. PT Bhuwanatala operates in hotel management, retail properties, and office space. The company listed its shares on Over-The Counter Market, and since the merger of the OTC Market with the Surabaya Stock Exchange, the shares automatically listed on the SSX.
Read more on BIPP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →